Celldex Therapeutics CLDX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's interest income?
- Celldex Therapeutics (CLDX) reported interest income of $5.75M in Q1 2026.
- How has Celldex Therapeutics's interest income changed year-over-year?
- Celldex Therapeutics's interest income decreased by 35.7% year-over-year, from $8.94M to $5.75M.
- What is the long-term trend for Celldex Therapeutics's interest income?
- Over 4 years (2021 to 2025), Celldex Therapeutics's interest income has grown at a 174.3% compound annual growth rate (CAGR), from $505K to $28.61M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.